Holly Hall

Bachelor of Medicine and Bachelor of Science,  The Johns Hopkins Hospital 

Location: Germany

Consulting Services

Pharma-CRO-Device Data Science-Bioinformatics Research Consulting Scientific Writing Grant Submission

Areas Of Interest

Inversion of Circadian Rhythm, Psychogenic Inorganic Biochemistry Investigator Subject Relations Technic, Planning Adenocarcinomas, Lung Fatty Acids, Omega 6 DepoProvera Diet, Diabetic Otospongioses Antebrachiums Crystal, Liquid p-Chlorophenoxyisobutyrate Cancer, Salivary Gland K Lysine Acetyltransferases Basil Rhinopneumonitis Viruses, Equine Technique, Delphi Arabinofuranosylnucleosides F Box Proteins Inhibitors, CYP3A4 Human 4F2 Antigen Monitors, Blood Pressure Outer Ears Antibodies, Humanized Cymarin Podophyllum peltatum Sewage Dithioerythreitol Gene, Ochre Suppressor M&B-39831 Negative-Pressure Dressing Kinase, c-Mer Tyrosine Gas Embolisms Hemi-Body Irradiation Canasa Dichlorophenol Indophenol

Professional Narrative

Dr. Holly Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 2000
Director Medicine, Harvard Med 1987

Education

Director Medicine, Weill Medical College 2019
Bachelor of science in nursing, Weill Medical College 2013

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :